Prostate cancer is often associated with metastases to bone and/or soft tissue. The
progression to metastatic castrate-resistant prostate cancer is a seminal event in disease …

The ability to identify prostate cancer patients at 'high risk'for bone metastasis development
could allow early selection of those most likely to benefit from interventions to prevent or …

Background The primary objective was to compare the overall diagnostic performance,
presented as detection rate of 68 Ga-PSMA-HBED-CC positron emission …

Objective To evaluate the performance of published guidelines compared with that of current
practice for radiographic staging of men with newly diagnosed prostate cancer. Materials …

Background International guidelines uniformly suggest no routine staging of bone
metastasis in patients with bone scintigraphy (BS) in low-risk prostate cancer (PCa). These …

We collected clinical data from 308 prostate cancer (PCa) patients to investigate the clinical
characteristics and independent risk factors of bone metastasis (BM) and to establish a …

Background: One of the important tumor markers having critically important applications in
every aspect of treating men with prostatic illness is prostate-specific antigen (PSA), formed …

Background To determine when a bone scintigraphy investigation is appropriate in patients
with newly diagnosed prostate cancer (PCa). Methods We retrospectively reviewed 703 …

Objective (s): Prostate cancer (PC) is the most common cancer in men over 50 years of age.
Bone scintigraphy is still performed in many institutions at the time of primary diagnosis. We …

Introduction: The purpose of this study was to identify clinical profiles of patients with low risk
of having bone metastases, for which bone scanning could be safely eliminated. Materials …